Can Psychedelic Ayahuasca Help With Depression?


Paul Melancon, Atlanta.


International Journal of Drug Policy: “The globalization of ayahuasca: Harm reduction or benefit maximization?”

Alli Feduccia, PhD, senior clinical data scientist, Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA.

Mayo Clinic: “Monoamine oxidase inhibitors (MAOIs).”

Multidisciplinary Association for Psychedelic Studies: “Ayahuasca.”

United States Drug Enforcement Administration: “Drug Scheduling.”

David Olson, PhD, assistant professor, department of biochemistry and molecular medicine and department of chemistry, University of California, Davis.


Frontiers in Pharmacology: “The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization.”

Jonathan Goldman, Essential Light Institute, Bend, OR.

Leave a Reply

Your email address will not be published. Required fields are marked *